Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects
Bazi Bushen capsule (BZBS), as a Chinese medicine used to relieve fatigue, has been proven effective for the treatment of atherogenesis through antilipid effects. To investigate the potential mechanism of BZBS in the anti-atherosclerotic effect, Ovx/ApoE-/- mice were applied to investigate the anti-...
Main Authors: | Dan Huang, Xindong Wang, Yunhong Zhu, Juexiao Gong, Junqing Liang, Yanfei Song, Yiyan Zhang, Linsheng Liu, Cong Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.658998/full |
Similar Items
-
Corrigendum: Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects
by: Dan Huang, et al.
Published: (2021-10-01) -
Mechanism of Bazi Bushen capsule in delaying the senescence of mesenchymal stem cells based on network pharmacology and experimental validation
by: Yaping Zhang, et al.
Published: (2024-03-01) -
Bazi Bushen ameliorates age-related energy metabolism dysregulation by targeting the IL-17/TNF inflammatory pathway associated with SASP
by: Xiaogang Shen, et al.
Published: (2024-04-01) -
Repositioning of clinically approved drug Bazi Bushen capsule for treatment of Aizheimer's disease using network pharmacology approach and in vitro experimental validation
by: Tongxing Wang, et al.
Published: (2023-07-01) -
Molecular mechanism of Bushen Huatan Prescription in the treatment of Polycystic ovary syndrome based on network pharmacology and bioinformatics
by: Linhui Huang, et al.
Published: (2022-12-01)